BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 4559404)

  • 1. Intensive combined chemotherapy and radiotherapy in patients with nonresectable bronchogenic carcinoma.
    Hansen HH; Muggia FM; Andrews R; Selawry OS
    Cancer; 1972 Aug; 30(2):315-24. PubMed ID: 4559404
    [No Abstract]   [Full Text] [Related]  

  • 2. Preliminary report on the treatment of nonresectable cancer of the lung.
    Kaung DT; Wolf J; Hyde L; Zelen M
    Cancer Chemother Rep; 1974; 58(3):359-64. PubMed ID: 4276322
    [No Abstract]   [Full Text] [Related]  

  • 3. A combination of cyclophosphamide, methotrexate, vincristine and VP 16-213 (NSC 141 540) in the treatment of bronchogenic carcinoma.
    Cavalli F; Hasler E; Ryssel HJ; Sonntag RW; Brunner KW
    Tumori; 1977; 63(2):169-73. PubMed ID: 898287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BCNU (1,3-bis(2-chloroethyl)-1-nitrosourea; NSC-409962) in the treatment of malignant brain tumor--a preliminary report.
    Walker MD; Hurwitz BS
    Cancer Chemother Rep; 1970 Aug; 54(4):263-71. PubMed ID: 4946011
    [No Abstract]   [Full Text] [Related]  

  • 5. Chemotherapy as an adjunct to surgery in the treatment of pulmonary malignant disease.
    Mountain CF
    Acta Chir Belg; 1971 Apr; 70(4):351-64. PubMed ID: 5143081
    [No Abstract]   [Full Text] [Related]  

  • 6. Coordinated treatment of childhood rhabdomyosarcoma with surgery, radiotherapy, and combination chemotherapy.
    Pratt CB; Hustu HO; Fleming ID; Pinkel D
    Cancer Res; 1972 Mar; 32(3):606-10. PubMed ID: 4551437
    [No Abstract]   [Full Text] [Related]  

  • 7. [VP 16-213 in combination with endoxan, methotrexate and oncovin as polychemotherapy for bronchogenic carcinoma].
    Ryssel HJ; Hasler E; Sonntag RW; Cavalli F; Martin J; Tschopp L; Brunner KW
    Schweiz Med Wochenschr; 1977 Jul; 107(26):912-5. PubMed ID: 877537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the combination of hexamethylmelamine (NSC-13875) and methotrexate (NSC-740) in carcinoma of the lung.
    Weiss AJ; Wilson WL
    Cancer Chemother Rep; 1971 Jun; 55(3):299-302. PubMed ID: 5115850
    [No Abstract]   [Full Text] [Related]  

  • 9. Chemotherapy for lung cancer at the Institute of Experimental and Clinical Oncology, Academy of Medical Sciences, USSR.
    Perevodchikova NI; Bychkov MB
    Cancer Chemother Rep 3; 1973 Mar; 4(2):251-5. PubMed ID: 4199645
    [No Abstract]   [Full Text] [Related]  

  • 10. Combination chemotherapy of advanced lung cancer: a randomized trial.
    Hansen HH; Selawry OS; Simon R; Carr DT; van Wyk CE; Tucker RD; Sealy R
    Cancer; 1976 Dec; 38(6):2201-7. PubMed ID: 187312
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination chemotherapy of bronchogenic carcinoma. I. Non-oat cell.
    Livingston RB
    Cancer Treat Rev; 1977 Sep; 4(3):153-65. PubMed ID: 73419
    [No Abstract]   [Full Text] [Related]  

  • 12. Combination chemotherapy with cyclophosphamide, vincristine, methyl-CCNU, and bleomycin in advanced bronchogenic carcinoma: experience with 106 patients.
    Samson MK; Baker LH; Fraile RJ; Izbicki RM; Vaitkevicius VK
    Cancer Treat Rep; 1977; 61(1):59-64. PubMed ID: 67895
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent therapeutic developments in lung cancer.
    Hansen HH; Selawry OS
    Med Ann Dist Columbia; 1971 Sep; 40(9):580-2. PubMed ID: 4939062
    [No Abstract]   [Full Text] [Related]  

  • 14. Radiotherapy for bronchogenic carcinoma: actual difficulties and plans for the future.
    Dana M
    Cancer Chemother Rep 3; 1973 Mar; 4(2):153-5. PubMed ID: 4734076
    [No Abstract]   [Full Text] [Related]  

  • 15. Combination chemotherapy with methyl-CCNU (NSC-95441), cyclophosphamide (NSC-26271), vincristine (NSC-67574), methotrexate (NSC-740), and bleomycin (NSC-125066) in advanced bronchogenic carcinoma.
    McMahon LJ; Jones SE; Durie BG; Salmon SE
    Cancer Lett; 1975 Nov; 1(2):97-102. PubMed ID: 65213
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclophosphamide (NSC-26271) as adjuvant to radiotherapy in the treatment of unresectable bronchogenic carcinoma.
    Host H
    Cancer Chemother Rep 3; 1973 Mar; 4(2):161-4. PubMed ID: 4729319
    [No Abstract]   [Full Text] [Related]  

  • 17. BCNU (NSC-409962) in the treatment of bronchogenic carcinoma.
    Whittington RM; Fairly JL; Majima H; Patno ME; Prentice R
    Cancer Chemother Rep; 1972 Dec; 56(6):739-43. PubMed ID: 4574055
    [No Abstract]   [Full Text] [Related]  

  • 18. Chemotherapy of bronchogenic carcinomas by a combination of cyclophosphamide, methotrexate, vincristin and bleomycin.
    Schaerer R; Sotto JJ; Wiget U; Perdrix A; Bensa JC; Ribaud P
    Eur J Cancer (1965); 1977; 13(4-5):425-8. PubMed ID: 68881
    [No Abstract]   [Full Text] [Related]  

  • 19. Chemotherapy in bronchogenic carcinoma.
    Ojala A; Nikkanen VN; Palojoki A; Paloheimo S
    Ann Clin Res; 1977 Feb; 9(1):12-4. PubMed ID: 329741
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Split-course irradiation compared to split-course irradiation plus hydroxyurea in inoperable bronchogenic carcinoma--a randomized study of 53 patients.
    Landgren RC; Hussey DH; Barkley HT; Samuels ML
    Cancer; 1974 Nov; 34(5):1598-601. PubMed ID: 4426027
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.